We serve Chemical Name:(S)-4-Hydroxypiperidin-2-one CAS:476014-92-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(S)-4-Hydroxypiperidin-2-one
CAS.NO:476014-92-3
Synonyms:2-Piperidinone, 4-hydroxy-, (4S)-;(4S)-4-hydroxypiperidin-2-one;(4S)-4-Hydroxy-2-piperidinone
Molecular Formula:C5H9NO2
Molecular Weight:115.131
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:352.3±35.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.498
PSA:52.82000
Exact Mass:115.063332
LogP:-2.16
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Piperidinone, 4-hydroxy-, (4S)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4S)-4-Hydroxy-2-piperidinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Piperidinone, 4-hydroxy-, (4S)- Use and application,(4S)-4-hydroxypiperidin-2-one technical grade,usp/ep/jp grade.
Related News: AstraZeneca acquired global rights to anifrolumab through an exclusive license and collaboration agreement with Medarex, Inc. in 2004. Medarex was acquired by Bristol-Myers Squibb in 2009. (24R)-5-campestene manufacturers Over the past two to three years, VBP has become “quite a challenge,” AZ’s international and China market chief Leon Wang said on the call. In response, the company has resorted to multichannel marketing, turning to the retail pharmacy market to soften the blow of tender losses. (6R,7R)-7-[(R)-2-tert-Butoxycarbonylamino-2-(3-methyl-benzo[b]thiophen-7-yl)-acetylamino]-3-methyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid 4-nitro-benzyl ester suppliers In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. 7-chloro-1-methyl-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-2-ol vendor & factory.
